| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 43 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.00M | - | |
| CFO | 58.4K | $16.24M | - | |
| VP | 29.8K | $8.28M | - | |
| VP | 23.7K | $6.59M | - | |
| Dir | 23.2K | $6.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | Pyott David E I | Director | Sale+OE | 32,450 | $220.69 | $7,161,360.00 | -58.8% | +22.0% | +45.8% | |
| May 29, 2024 | Schulman Amy W | Director | Sale+OE | 21,700 | $148.60 | $3,224,546.17 | -37.0% | +90.7% | +99.3% | |
| Feb 29, 2024 | Sharp Phillip A45 | Director | Sale+OE | 30,000 | $151.34 | $4,540,070.94 | -55.5% | -2.8% | +63.3% | |
| Feb 28, 2024 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sale+OE | 574 | $155.30 | $89,144.57 | -0.6% | -3.3% | +52.7% | |
| Feb 28, 2024 | Greenstreet Yvonne49 | Chief Executive Officer | Sale+OE | 2,932 | $155.31 | $455,357.07 | -1.2% | -3.3% | +52.7% | |
| Feb 28, 2024 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sale+OE | 574 | $155.30 | $89,144.57 | -1.3% | -3.3% | +52.7% | |
| Feb 28, 2024 | Franchini Indrani Lall56 | EVP, CLO &Secretary | Sale+OE | 329 | $155.30 | $51,094.50 | -1.5% | -3.3% | +52.7% | |
| Feb 28, 2024 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sale+OE | 501 | $155.30 | $77,805.43 | -1.8% | -3.3% | +52.7% | |
| Feb 16, 2024 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 1,007 | $148.06 | $149,099.42 | -1.8% | +2.9% | +74.5% | |
| Feb 16, 2024 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sell | 1,308 | $148.06 | $193,665.96 | -5.4% | +2.9% | +74.5% |